Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
88
Views
8
CrossRef citations to date
0
Altmetric
Review

Targeted treatment of advanced ovarian cancer: spotlight on rucaparib

Diana C PearreDivision of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of California, Irvine Medical Center, Orange, CA, USA, [email protected]
&
Krishnansu S TewariDivision of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of California, Irvine Medical Center, Orange, CA, USA, [email protected]Correspondence[email protected]
Pages 2189-2201 | Published online: 02 Nov 2018

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jarosław Przybycinski, Magdalena Nalewajska, Małgorzata Marchelek-Mysliwiec, Violetta Dziedziejko & Andrzej Pawlik. (2019) Poly-ADP-ribose polymerases (PARPs) as a therapeutic target in the treatment of selected cancers. Expert Opinion on Therapeutic Targets 23:9, pages 773-785.
Read now

Articles from other publishers (7)

Biyu Zhang, Chen Tang, Yanli Yao, Xiaohan Chen, Chi Zhou, Zhiting Wei, Feiyang Xing, Lan Chen, Xiang Cai, Zhiyuan Zhang, Shuyang Sun & Qi Liu. (2021) The tumor therapy landscape of synthetic lethality. Nature Communications 12:1.
Crossref
Abdulrahim Gari, Ghufran Rawas, Ahmad Mufti & Omima Elemam. (2021) BRCA Mutations and PARP Inhibitors in Breast and/or Ovarian Cancer Patients. International Journal Of Pharmaceutical Research And Allied Sciences 10:3, pages 33-49.
Crossref
Erin G. Hartnett, Julia Knight, Mackenzy Radolec, Ronald J. Buckanovich, Robert P. Edwards & Anda M. Vlad. (2020) Immunotherapy Advances for Epithelial Ovarian Cancer. Cancers 12:12, pages 3733.
Crossref
Mausam Patel, Somaira Nowsheen, Sanjay Maraboyina & Fen Xia. (2020) The role of poly(ADP-ribose) polymerase inhibitors in the treatment of cancer and methods to overcome resistance: a review. Cell & Bioscience 10:1.
Crossref
Ming Yi, Bing Dong, Shuang Qin, Qian Chu, Kongming Wu & Suxia Luo. (2019) Advances and perspectives of PARP inhibitors. Experimental Hematology & Oncology 8:1.
Crossref
Zhi-Ying Qi, Fang Wang, Ying-Ying Yue, Xue-Wang Guo, Rui-Meng Guo, Hong-Lin Li & Yan-Ying Xu. (2019) CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo. Journal of Ovarian Research 12:1.
Crossref
Liulin Tang, Bin Yang, Xiaolan Cao, Qin Li, Li Jiang & Dan Wang. (2019) MicroRNA-377-3p inhibits growth and invasion through sponging JAG1 in ovarian cancer. Genes & Genomics 41:8, pages 919-926.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.